• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注意缺陷多动障碍青少年对哌甲酯作用的归因与认知

Attributions and Perception of Methylphenidate Effects in Adolescents With ADHD.

作者信息

Pelham William E, Gnagy Elizabeth M, Sibley Margaret H, Kipp Heidi L, Smith Bradley H, Evans Steven W, Bukstein Oscar

机构信息

1 Florida International University, Miami, USA.

2 University of Pittsburgh Medical Center, PA, USA.

出版信息

J Atten Disord. 2017 Jan;21(2):129-136. doi: 10.1177/1087054713493320. Epub 2016 Jul 28.

DOI:10.1177/1087054713493320
PMID:23893533
Abstract

OBJECTIVE

Although a number of studies demonstrate that children with ADHD do not attribute their behavior to taking medication, it remains unstudied whether adolescents, who have a longer history of taking medication for ADHD, show performance attributions to medication.

METHOD

A sample of 46 adolescents completed daily attributions for success or failure as a part of their participation in a summer treatment program with a double-blind, placebo-controlled assessment of methylphenidate.

RESULTS

Results demonstrated that adolescents with ADHD did not reliably discern active medication from placebo, rarely attributed their performance to the pill, and showed no differences in attributional style as a function of medication status.

CONCLUSION

These data indicate that adolescents with ADHD may possess inaccurate beliefs about the effect of stimulant medication on their behavior.

摘要

目的

尽管多项研究表明患有注意力缺陷多动障碍(ADHD)的儿童不会将自己的行为归因于服药,但对于有更长ADHD服药史的青少年是否会将表现归因于药物,仍未进行研究。

方法

46名青少年参与了一项暑期治疗项目,该项目对哌甲酯进行双盲、安慰剂对照评估,作为项目的一部分,他们完成了对成功或失败的每日归因。

结果

结果表明,患有ADHD的青少年无法可靠地区分活性药物和安慰剂,很少将自己的表现归因于药物,并且在归因方式上未表现出因药物状态而产生的差异。

结论

这些数据表明,患有ADHD的青少年可能对刺激性药物对其行为的影响持有不准确的信念。

相似文献

1
Attributions and Perception of Methylphenidate Effects in Adolescents With ADHD.注意缺陷多动障碍青少年对哌甲酯作用的归因与认知
J Atten Disord. 2017 Jan;21(2):129-136. doi: 10.1177/1087054713493320. Epub 2016 Jul 28.
2
Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence.儿童和青少年期注意缺陷多动障碍兴奋剂治疗的等效效果。
J Am Acad Child Adolesc Psychiatry. 1998 Mar;37(3):314-21. doi: 10.1097/00004583-199803000-00017.
3
Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder.患有注意力缺陷多动障碍男孩的哌甲酯与归因
J Consult Clin Psychol. 1992 Apr;60(2):282-292. doi: 10.1037/0022-006X.60.2.282.
4
Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.随机、双盲、安慰剂对照急性对照试验:右苯丙胺和哌甲酯缓释剂治疗青少年注意缺陷多动障碍。
CNS Drugs. 2017 Nov;31(11):999-1014. doi: 10.1007/s40263-017-0468-2.
5
Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.茶碱与哌甲酯治疗儿童及青少年注意力缺陷多动障碍的疗效比较:一项双盲随机试验的初步研究
J Clin Pharm Ther. 2004 Apr;29(2):139-44. doi: 10.1111/j.1365-2710.2004.00545.x.
6
Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.丁螺环酮与哌甲酯治疗儿童注意力缺陷/多动障碍的随机双盲研究
Acta Med Iran. 2012;50(11):723-8.
7
Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.随机对照双盲试验研究最佳剂量哌醋甲酯治疗伴有严重注意缺陷多动障碍和智力障碍的儿童和青少年。
J Child Psychol Psychiatry. 2013 May;54(5):527-35. doi: 10.1111/j.1469-7610.2012.02569.x. Epub 2012 Jun 7.
8
The effect of a skipped dose (placebo) of methylphenidate on the learning and retention of a motor skill in adolescents with Attention Deficit Hyperactivity Disorder.一次漏服(安慰剂)哌甲酯对患有注意力缺陷多动障碍青少年运动技能学习及保持的影响。
Eur Neuropsychopharmacol. 2014 Mar;24(3):391-6. doi: 10.1016/j.euroneuro.2013.11.005. Epub 2013 Dec 1.
9
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.盐酸哌甲酯控释片治疗青少年注意力缺陷/多动障碍的多中心对照研究。
Arch Pediatr Adolesc Med. 2006 Jan;160(1):82-90. doi: 10.1001/archpedi.160.1.82.
10
Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.盐酸哌甲酯缓释胶囊(Aptensio XR™)治疗儿童和青少年注意力缺陷/多动障碍的疗效:一项III期随机双盲研究。
CNS Drugs. 2015 Apr;29(4):331-40. doi: 10.1007/s40263-015-0241-3.

引用本文的文献

1
Linking Adherence to Effectiveness in Family-Based Adolescent ADHD Academic Training and Medication Decision-Making Protocols.在基于家庭的青少年注意力缺陷多动障碍学术训练及药物治疗决策方案中,将依从性与有效性相联系。
J Clin Child Adolesc Psychol. 2025 Jan 30:1-15. doi: 10.1080/15374416.2025.2454640.
2
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
3
Pilot Evaluation of the Medication Integration Protocol for Adolescents with ADHD in Behavioral Care: Treatment Fidelity and Medication Uptake.
行为护理中多动症青少年药物整合方案的试点评估:治疗依从性和药物接受情况
J Emot Behav Disord. 2016 Dec 1;24(4):223-234. doi: 10.1177/1063426615611648. Epub 2015 Oct 30.
4
Changing Academic Support in the Home for Adolescents with Attention-Deficit/Hyperactivity Disorder: A Family-Based Clinical Protocol for Improving School Performance.改变对患有注意力缺陷多动障碍青少年的家庭学业支持:一项基于家庭的改善学校表现的临床方案。
Cogn Behav Pract. 2016 Feb;23(1):14-30. doi: 10.1016/j.cbpra.2014.07.002. Epub 2014 Jul 25.
5
Randomized Trial of Academic Training and Medication Decision-Making for Adolescents with ADHD in Usual Care.随机临床试验:在常规护理中对患有 ADHD 的青少年进行学术培训和药物决策。
J Clin Child Adolesc Psychol. 2021 Nov-Dec;50(6):874-887. doi: 10.1080/15374416.2020.1716362. Epub 2020 Feb 20.
6
A Clinician's Guide to Co-occurring ADHD among Adolescent Substance Users: Comorbidity, Neurodevelopmental Risk, and Evidence-based Treatment Options.青少年药物使用者中共患注意力缺陷多动障碍的临床医生指南:共病、神经发育风险及循证治疗方案
J Child Adolesc Subst Abuse. 2017;26(4):277-292. doi: 10.1080/1067828X.2017.1305930. Epub 2017 Apr 24.
7
Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder During Adolescence in the Primary Care Setting: A Concise Review.基层医疗环境中青少年注意力缺陷多动障碍的诊断与治疗:简要综述
J Adolesc Health. 2016 Aug;59(2):135-43. doi: 10.1016/j.jadohealth.2016.03.025. Epub 2016 May 18.
8
Clinical Strategies for Integrating Medication Interventions Into Behavioral Treatment for Adolescent ADHD: The Medication Integration Protocol.将药物干预整合到青少年注意力缺陷多动障碍行为治疗中的临床策略:药物整合方案。
Child Fam Behav Ther. 2014 Oct 1;36(4):280-304. doi: 10.1080/07317107.2014.967631.